{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:33:48Z","timestamp":1777937628865,"version":"3.51.4"},"reference-count":12,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.7883\/yoken.jjid.2025.231","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:09:44Z","timestamp":1777500584000},"source":"Crossref","is-referenced-by-count":0,"title":["Questionnaire-based analysis of infection control and prevention strategies against COVID-19 in hematopoietic stem cell transplantation units in Japan, 2023"],"prefix":"10.7883","author":[{"given":"Takashi","family":"Sakoh","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Pathology, National Institute for Infectious Diseases, Japan, Institute for Health Security, Japan"},{"name":"Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Araoka","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Toranomon Hospital, Japan"},{"name":"Okinaka Memorial Institute for Medical Research, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pagano L, Salmanton-Garc\u00eda J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood 2022; 140(26): 2773-87.","DOI":"10.1182\/blood.2022017257"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mart\u00ednez-L\u00f3pez J, de la Cruz J, Gil-Manso R, et al. COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant. Cancers (Basel) 2024; 16(2).","DOI":"10.3390\/cancers16020379"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nussenblatt V, Roder AE, Das S, et al. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion. J Infect Dis 2022; 225(7): 1118-23.","DOI":"10.1093\/infdis\/jiab622"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dioverti V, Boghdadly ZE, Shahid Z, et al. Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022). Transplant Cell Ther 2022; 28(12): 810-21.","DOI":"10.1016\/j.jtct.2022.09.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cesaro S, Ljungman P, Mikulska M, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia 2022; 36(6): 1467-80.","DOI":"10.1038\/s41375-022-01578-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cesaro S, Mikulska M, Hirsch HH, et al. Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9). Leukemia 2023; 37(9): 1933-8.","DOI":"10.1038\/s41375-023-01938-5"},{"key":"7","unstructured":"7. CDC. Infection Control Guidance: SARS-CoV-2. Centers for Disease Control and Prevention, https:\/\/wwwcdcgov\/covid\/hcp\/infection-control\/indexhtml 2023."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Orchard K, Dignan FL, Lee J, et al. The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact. Br J Haematol 2021; 192(3): 467-73.","DOI":"10.1111\/bjh.17280"},{"key":"9","unstructured":"9. NICE. COVID-19 rapid guideline: haematopoietic stem cell transplantation. National Institute for Health and Care Excellence 2023."},{"key":"10","unstructured":"10. CDC. Overview of Testing for SARS-CoV-2, the virus that causes COVID-19. Centers for Disease Control and Prevention, https:\/\/wwwcdcgov\/covid\/hcp\/clinical-care\/overview-testing-sars-cov-2html#:~:text=Antibody%20tests%20detect%20specific%20antibodies,SARS%2DCoV%2D2%20infection 2023."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cesaro S, Ljungman P, Mikulska M, et al. Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10). Leukemia 2025.","DOI":"10.1038\/s41375-025-02649-9"},{"key":"12","unstructured":"12. CDC. Ending Isolation and Precautions for People with COVID-19: Interim Guidance. Centers for Disease Control and Prevention, https:\/\/archivecdcgov\/#\/details?q=https:\/\/wwwcdcgov\/coronavirus\/2019-ncov\/hcp\/duration-isolationhtml&start=0&rows=10&url=https:\/\/wwwcdcgov\/coronavirus\/2019-ncov\/hcp\/duration-isolationhtml 2023."}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2025.231\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:11:34Z","timestamp":1777695094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/advpub\/0\/advpub_JJID.2025.231\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2025.231","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"JJID.2025.231"}}